Iulian studied physics at the University of Bucharest, and he sees himself as a physicist in the broadest sense of the word. He also studied economics at Charles University in Prague and Central European University in Budapest, after a master’s program in business administration at Bucharest Academy of Economic Studies. Since recently, he’s been exploring coding and data analysis for business and economics. As a freelancer, he worked for nearly two decades as an analyst for ISI Emerging Markets, Euromonitor International, Business New Europe, but also as a consultant for OMV Petrom and UkrAgroConsult. Iulian was part of the founding team of Ziarul Financiar. At Romania Insider, which he joined in 2018, he is reviewing the latest economic developments for the premium bulletins and newsletters. He would gladly discuss topics such as macroeconomics, emerging markets, Prague, energy sector including renewable, Led Zeppelin, financial services, as well as tech start-ups and innovative technologies. Email him at iulian@romania-insider.com.
The new European Commission must come up with "a much more sustainable approach for the car industry
Rural entrepreneurs lost the long-awaited financing line DR-29, with a budget of EUR 150mn for non
Romania's prime minister Marcel Ciolacu announced that the Government reached an agreement with the
The Government of Romania has decided that the minimum gross statutory wage will increase to RON 4
ROCA Industry, the industrial holding specialized in the production of construction materials
The president of the junior ruling Liberal Party, Nicolae Ciucă, urged prime minister Marcel Ciolacu
Ford announced on October 15 that it will open in November waiting lists for Romania customers
Two new private equity funds - Evolving Europe Principal Investments Fund II and Finance in Motion
UniCredit downgraded its 2024 growth forecast for Romania to 1.7% (from 2.4% in July) due to the
The medium-term fiscal plan that Romania is supposed to send to the European Commission (EC) this
Romania’s industrial production index plunged by 4.2% y/y in August, marking one of the most